Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Granules India gets EIR from USFDA for Paracetamol, Metformin API manufacturing plant

      Granules India gets EIR from USFDA for Paracetamol, Metformin API manufacturing plant

      Medical Dialogues Bureau15 Sept 2019 9:30 AM IST
      Bonthapally facility is one of the world’s largest single-site Paracetamol API manufacturing plant by volume. Along with Paracetamol APIs, the...
      Medical Devices Sector: CII seeks Government to bring trade margin rationalisation

      Medical Devices Sector: CII seeks Government to bring trade margin rationalisation

      Medical Dialogues Bureau15 Sept 2019 9:15 AM IST
      The government is planning to come out with a Medical Devices Act which is going to be put in public domain shortly, Baid said adding, "The medical...
      Everstone-backed Everlife names Raman Gandotra as new CEO

      Everstone-backed Everlife names Raman Gandotra as new CEO

      Medical Dialogues Bureau15 Sept 2019 9:00 AM IST
      Prior to joining Everlife, Raman Gandotra was leading the India and South-East Asia business of Smith & Nephew, Baxter and Allergan.New Delhi:...
      UK drug regulator MHRA reinstates full GMP status to Indoco Goa Plant I

      UK drug regulator MHRA reinstates full GMP status to Indoco Goa Plant I

      Medical Dialogues Bureau14 Sept 2019 11:52 AM IST
      UK-MHRA conducted a ‘Focused Audit’ in October 2018 and GMP audit in May 2019. These audits were completed with no Critical Observations and Indoco...
      Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

      Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

      Medical Dialogues Bureau14 Sept 2019 9:16 AM IST
      Director-general of Pharmexcil, a body under the Ministry of Commerce and Industry, Uday Bhasker said some of the policy decisions being taken by the...
      Bayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLT

      Bayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLT

      Medical Dialogues Bureau14 Sept 2019 9:15 AM IST
      Bayer CropScience took shareholders' approval for the merger during the first quarter of 2019-20 and was waiting for the final approval of the NCLT to...
      Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

      Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

      Medical Dialogues Bureau14 Sept 2019 9:15 AM IST
      Valisure said in its report that it found the impurity in both Sanofi SA's branded Zantac as well as generic versions of the drug. But the FDA would...
      Biocon inks license, supply pact with CMS for 3 generic formulations

      Biocon inks license, supply pact with CMS for 3 generic formulations

      Medical Dialogues Bureau13 Sept 2019 2:45 PM IST
      Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
      Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

      Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

      Medical Dialogues Bureau13 Sept 2019 11:59 AM IST
      The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations...
      First AI-powered X-ray System: GE Healthcare bags USFDA approval

      First AI-powered X-ray System: GE Healthcare bags USFDA approval

      Medical Dialogues Bureau13 Sept 2019 9:30 AM IST
      Built-in collaboration with UC San Francisco (UCSF), using GE Healthcare's Edison platform, the AI algorithms help to reduce the turn-around time it...
      Investigate, block AbbVie, Allergan USD 63 billion merger: Consumer Groups to Trade Commission

      Investigate, block AbbVie, Allergan USD 63 billion merger: Consumer Groups to Trade Commission

      Medical Dialogues Bureau13 Sept 2019 9:20 AM IST
      The combination of two of the world's biggest pharmaceutical companies, which was announced in June, would feature a portfolio that includes the...
      Aspen Pharma gets USFDA nod for HPC to prevent preterm birth in pregnant women

      Aspen Pharma gets USFDA nod for HPC to prevent preterm birth in pregnant women

      Medical Dialogues Bureau13 Sept 2019 9:15 AM IST
      Aspen, which operates in about 56 countries, has said before that it views the United States as presenting targeted growth opportunities for its niche...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok